EGFR pathway and its main downstream effectors (top)
An overview of the EGFR pathway and its main downstream effectors (top). Expected outcomes of anti-EGFR (mAb) therapy (bottom): sensitivity (tumour response) when EGFR is activated (gain copy number, ligand overexpression, other unknown mechanisms) and downstream effectors are wild type (left); resistance (tumour development and metastasis) when downstream effectors such as KRAS, BRAF or PI3K are activated or PTEN is inactivated (right).
Publication
Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer. (2010) F Di Fiore, et al. Br J Cancer. 2010 Dec 7;103(12):1765-1772. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | EGFR | EGFR | ncbigene_symbol | EGFR | 1956 |
| Homo sapiens | Primates | KRAS | KRAS | ncbigene_symbol | KRAS | 3845 |
| Homo sapiens | Primates | KRAS | KRAS | ncbigene_synonym | NRAS | 4893 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | BRAF | BRAF | ncbigene_symbol | BRAF | 673 |
| Homo sapiens | Primates | PTEN | PTEN | ncbigene_symbol | PTEN | 5728 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | MEK/ERK | MEK | ncbigene_synonym | MAP2K7 | 5609 |
| Homo sapiens | Primates | MEK/ERK | MEK | famplex_relations | MAP2K1 | 5604 |
| Homo sapiens | Primates | MEK/ERK | MEK | famplex_relations | MAP2K2 | 5605 |
| Homo sapiens | Primates | MEK/ERK | ERK | ncbigene_synonym | EPHB2 | 2048 |
| Homo sapiens | Primates | MEK/ERK | ERK | ncbigene_synonym | MAPK1 | 5594 |
| Homo sapiens | Primates | MEK/ERK | ERK | famplex_relations | MAPK3 | 5595 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| Cancer | NA | |||
| Lung cancer | NA |